Biosimilars Market Research Report – Segmented by Product Type (Monoclonal Antibodies, Recombinant Hormones, Immunomodulators, Anti-Inflammatory Agents, and Others); By Therapeutic Application (Oncology, Autoimmune Diseases, Hematology Disorders, Infectious Diseases, Endocrine Disorders, and Others); By Distribution Channels ( Hospital Pharmacies, Speciality Clinics and Centers, Retail Pharmacies, Online Pharmacies, and Others); and Region - Size, Share, Growth Analysis | Forecast (2023 – 2030)
Choose License Type
$
2500
$
4250
$
5250
$
6900
Frequently Asked Questions
The Global Biosimilars Market was estimated to be worth USD 29.98 Billion in 2023 and is anticipated to reach a value of USD 70.70 Billion by 2030, growing at a fast CAGR of 11.32% during the forecast period 2023-2030.
The global Biosimilars market is driven by factors such as cost savings, increasing demand for biologics, rising prevalence of chronic diseases and cancer, and supportive government initiatives.
Monoclonal Antibodies, Insulin, Growth Factors, Interferons, and Erythropoietin are segments under the Global Biosimilars Market by product type.
Europe dominates the market in Global Biosimilars Market.
Asia-Pacific is the fastest-growing region in the Global Biosimilars Market.
